Acute and Chronic Inflammatory Disease, Lifestyle and Treatment Response

Launched by WROCLAW MEDICAL UNIVERSITY · Dec 7, 2019

Keywords

ClinConnect Summary

This clinical trial is studying uveitis, which is an inflammation of the eye that can be challenging to treat and manage. The goal of the study is to identify new factors that might cause the disease to come back or help it stay under control. Researchers will also look at how lifestyle choices and other known factors affect treatment outcomes. Patients will be assigned to one of three treatment groups: those receiving only steroids, those getting a combination of steroids and another medication, or those on biologic therapy, which is a type of medication that targets specific parts of the immune system.

To participate, individuals must have either a new diagnosis of uveitis or a recurrence of a previously diagnosed case. The trial is open to all ages and genders, but participants need to be mentally capable of answering questionnaires about their health. During the study, participants will provide information about their health and lifestyle, and their treatment outcomes will be monitored over time to see how effective the different therapies are. This research aims to improve understanding of uveitis and help find better treatment options for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • new diagnosis of uni or bilateral uveitis
• • recurrence of the diagnosed previously uni or bilateral uveitis
• Exclusion Criteria:
• • not mentally able to reply the questionnaire